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This data article contains extended, complementary analysis rela-
ted to the research articles entitled “Desmoglein 3, via an inter-
action with E-cadherin, is associated with activation of Src” (Tsang
et al., 2010) [1] and ﬁgures related to the review article entitled
“Desmoglein 3: a help or a hindrance in cancer progression?”
(Brown et al., 2014) [2]. We show here that both Src and caveolin-1
(Cav-1) associate with Dsg3 in a non-ionic detergent soluble pool
and that modulation of Dsg3 levels inversely alters the expression
of Src in the Cav-1 complex. Furthermore, immunoﬂuorescence
analysis revealed a reduced colocalization of Cav-1/total Src in cells
with overexpression of Dsg3 compared to control cells. In support,
the sequence analysis has identiﬁed a region within the carboxyl-
terminus of human Dsg3 for a likelihood of binding to the scaf-
folding domain of Cav-1, the known Src binding site in Cav-1, and
this region is highly conserved across most of 18 species as well as
within desmoglein family members. Based on these ﬁndings, we
propose a working model that Dsg3 activates Src through com-
peting with its inactive form for binding to Cav-1, thus leading to
release of Src followed by its auto-activation.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Value of the data
 Dsg3 forms a complex with Src, caveolin-1 and E-cadherin.
 Dsg3 competes with Src for binding to caveolin-1 and thus elicits Src auto-activation.
 A highly conserved putative region within the carboxyl-terminus of Dsg3 is identiﬁed for binding
to the scaffolding domain of caveolin-1.1. Data
The desmosomal cadherin, Desmoglein 3 (Dsg3) is a calcium-dependent adhesion protein in
epithelial cells and has recently been identiﬁed to associate with E-cadherin/Src and act as an
upstream regulator in E-cadherin/Src signaling [1–5]. However, the molecular mechanism by which
Dsg3 regulates Src remains poor understood. In vitro study showed that Dsg3 is internalized through a
lipid raft-mediated pathway upon PV-IgG binding [6] and lipid raft contains caveolin protein. Inter-
estingly, the Dsg3 associated family member Dsg2 is recently found to interact directly with the
scaffold domain of caveolin-1 [7]. Hence, we speculated that Dsg3 also forms a complex with
caveolin-1 along with Src. To investigate this possibility, we performed co-IP experiments with mouse
antibody against Dsg3 in Triton-soluble and insoluble fractions of HaCaT cells, respectively, using the
same procedures as previously described [1,4]. Western blotting of immunoprecipitates revealed that
both caveolin-1 and Src co-puriﬁed with Dsg3, alongside E-cadherin and actin, in particular from
Triton-soluble fraction (Fig. 1A). The proximity ligation assay (PLA) showed that, compared with the
negative control, there was a substantial increase of PLA signals in cells probed with either Dsg3/
caveolin-1 or Dsg3/Src antibody combinations (Fig. 1B left bar chart) and Dsg3 silencing resulted in a
reduced PLA signals as expected (data not shown).
Several lipid-regulated signaling molecules, including Src, Gα subunits and H-Ras, bind caveolin [8,9].
Src of inactivated form is identiﬁed to bind to a membrane-anchored scaffolding domain of caveolin; the
20aa stretch within a membrane-proximal region of the cytosolic N-terminal domain of caveolin [8] (see
cartoon in Fig. 5B). This 20aa residues functionally inhibit the auto-activation of c-Src and Fyn tyrosine
kinases [8]. Hence, we hypothesized that Dsg3 may compete with inactive Src for the same binding site
on caveolin. To test this hypothesis, we analyzed the immune complexes puriﬁed with caveolin-1 anti-
body in A431-Vect control and A431-hDsg3.myc cells with overexpression of Dsg3. Western blotting of
caveolin-1 immunoprecipitates showed that overexpression of Dsg3 increased its association with
caveolin-1 while reducing the amounts of Src in such a complex, compared to vector control cells (Fig. 1C
left panels). In parallel, co-IP was performed in HaCaTs with or without Dsg3 depletion. Western blotting
analysis of immunoprecipitates showed that Dsg3 silencing resulted in an increase in the amount of Src in
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Fig. 1. Dsg3 competes with Src for binding to caveolin-1. (A) Western blotting analysis of the Dsg3 immunoprecipitates from
Triton-soluble and insoluble fractions of HaCaT keratinocytes and probed with the indicated antibodies. (B) Proximity ligation
assay (PLA), left, for Dsg3 and Src or caveolin-1 (Cav-1) that showed the enhanced protein interaction signals for both Dsg3/Src
and Dsg3/Cav-1 and the representative images of PLA are displayed on the right. (C) Western blotting of immune complexes
puriﬁed with Cav-1 antibody from A431 and HaCaT cell lysates that showed the overexpression of Dsg3 resulted in a reduction
of Src in the caveolin complex, and an inverse effect was observed in cells with Dsg3 silencing (RNAi), compared to the
respective control cells (arrows). The densitometry of the Src was indicated above the Src blots. Scram: scrambled control
siRNA, HC: antibody heavy chain. (D) Confocal microscopy showed enhanced colocalisation of Dsg3/Cav-1 in cells with over-
expression of Dsg3 (A431-D3) compared to vector control cells (A431-V). Top panels are the projected images of the stacks
(with maximum intensity) and bottom ones are the orthogonal views if stacks. Scale bar, 10 µm.
H. Wan et al. / Data in Brief 6 (2016) 124–134126the complex puriﬁed by caveolin-1 antibody (Fig. 1C right panels). Furthermore, confocal analysis indi-
cated enhanced co-localization of Dsg3 and caveolin-1 at the plasma membrane in cells with over-
expression of Dsg3 relative to vector control cells (Fig. 1D).
To test our hypothesis further, we performed double immunostaining with antibody combination for
Cav-1/phospho-Src and Cav-1/total Src, respectively, followed by colocalization analysis with ImageJ. As
shown in Fig. 2, there was little colocalization for Cav-1/pSrc at the cell borders in A431 cells and pSrc was
predominantly expressed in the membrane protrusions. However, a marked increase in the colocalization
of Cav-1 and total Src was detected at the cell borders in A431-V cells but this was found to be reduced in
Dsg3 overexpressing cells (A431-D3) (see the colocalization images and proﬁles in Fig. 2B). Interestingly, a
reduced expression level of Cav-1 was also observed in A431-D3 cells compared to A431-V control in
which an enhanced Cav-1 staining at cell borders was noticeable.
The protein sequence analysis identiﬁes a putative region for binding the caviolin-1 scaffolding
domain enriched in aromatic amino acids [10] in Dsg3 which is highly conserved across most of 18
species (Fig. 3) as well as within the Dsg family members (Fig. 4). This potential binding site is located
within the ICS domain of C-terminus of Dsg3 at 788-798aa, an 11aa stretch which contains 4 aromatic
aa residues and which likely competes with the inactive Src for binding to the scaffolding domain in
caveolin-1 [10]. Interestingly, this region is overlapped with previously identiﬁed segment by Andi
and Stanley [11], the 87aa sequence within the ICS domain downstream from the 779aa, that is
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Fig. 2. The Dsg3 overexpressing cells showed reduced colocalization of caveolin-1 and total Src at cell periphery.
Immunoﬂuorescence and colocalization analysis of caveolin-1 (Cav-1, red)/phospho-Src (pSrc, green) (A) and Cav-1 (red)/total
Src (green) (B) in A431 cell lines. Cells were seeded at sub-conﬂuent density for one day and ﬁxed with ice cold Methanol for 10
min before proceeding immunoﬂuorescence (IMF) staining. (A) Little colocalization of Cav-1/pSrc was detected at the cell
periphery (highlighted in white pixels in the bottom two images). Phospho-Src was found predominantly expressed in the
membrane protrusions and was not co-localized with Cav-1. Reduced expression of Cav-1 was observed in A431-D3 cells
compared to A431-V control in which an enhanced Cav-1 staining at cell borders was noticeable. (B) A signiﬁcantly enhanced
colocalization of Cav-1/Src was seen in A431-V cells as compared with that for Cav-1/pSrc staining. The Dsg3 overexpressing
cells (A431-D3) showed relatively less colocalization than that of A431-V cells for Cav-1/total Src staining (highlighted white
pixels in the bottom two images). The proﬁles of IMF staining at cell borders for the marked cells (a and b) in A and B are
displayed on the right, respectively. The percentage of colocalization in each image was indicated at the bottom right corner.
Scale bar, 10 µm.
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Fig. 3. A conserved putative binding site is identiﬁed within the carboxyl-terminus of Dsg3 by sequence alignment.
Alignment of Dsg3 across 18 species using the program MUSCLE [14]. The putative binding site (box with red line), at amino
acid sequence between 788-798 with four aromatic amino acid residues (asterisks), for the scaffolding domain of caveolin-1
[10] is depicted to be conserved across 10 of 18 species. The amino acids are coloured according to the Clustal X Colouring
Scheme [15].
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Fig. 3. (continued)
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GF DPL L T QNV I VT ERV I CP I SSVP - - - GNL AGPT QL PT QL RGSRT ML CT EDPCSRL I
VF DPL L T QNVT VT ERV I CPVSNVP - - - GNL HG - - - - PME I RGSRT M I CT EDPCSRL I
VL EPL L T QNVT VT ERV I CP I SNVS - - - GNL QT - - - - PMEL RGSRNM I CT EDPCSRL I
VSDPL L T QSVT VT ERVVCPRAAVS - - - GSL I V - - - - PT EL RGSRS I L CT EDPCSRL I
VF DPL L T QNV I VT ERV I CPT PS I T - - - GNL HG - - - - PT EL RGSDSK I F T EDPSSRL I
T F DPHVT QNVT VT ERV I CPL PSAS - - - SS I VA - - - - PT EL RGSYNML YT KET CSHL -
T F DPHVT QNVT VT ERV I CPL PSAS - - - GS I VA - - - - PT EL RGSYSML YT KEACSHL -
VF DPRL T ENVT VT ERV I CP I SGVSG I QGNL NG - - - - PT QL GGSCNVT CT QDPCSRL I
F L DPQF KEN I VVT ERVL APASGL R - - - EMVE I - - - - PSL PSGKNMVVT ERML T SEGP
VHDNRQASNVVVT ERVVGP I SG - - - - - ANL HGML EMPDL RDGSNV I VT ERV I APNSS
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
*   **      *
Fig. 3. (continued)
H. Wan et al. / Data in Brief 6 (2016) 124–134130required for binding to plakoglobin and recruitment of Dsg3 to desmosomes. Study based on pla-
koglobin null keratinocytes by Green and colleagues has suggested that plakoglobin plays a role to
suppress Src activity [12]. Thus it is possible that when plakoglobin is ablated the excess free Dsg3
molecules compete with Src for binding the scaffolding domain of caveolin-1 thus elicits Src auto-
activation. In accord, when Dsg3 is overexpressed the same result would occur with a consequence of
Src activation.
Fig. 4. The putative binding site is conserved within human Dsg subfamily. The four family members of human Dsgs were
aligned using the program MUSCLE [14]. The putative binding site for the scaffolding domain of caveolin [10] is highlighted in
the box with a dotted line, in which four aromatic amino acid residues are depicted to be highly conserved across the family
members (asterisks).
H. Wan et al. / Data in Brief 6 (2016) 124–134 131Based on these ﬁndings we have proposed a working model that Dsg3 competes with inactive Src
for binding to the scaffolding domain of caveolin-1, and thus causes Src to release from binding to
caveolin-1, that leading to its auto-activation (Fig. 5B). This working model opens up a new avenue for
future research.
Ca++
Dsg3
N
C
N
Src
E-cad
N
C
N
pSrc
Dsg3
Cav:scaffolding
domain
E-cad
* * * *
Caveolae
Fig. 5. A proposed working model of how Dsg3 activates Src. (A) Amino acid sequence alignment of Dsg family members
showing highly conserved putative region (dotted line) for binding to the scaffolding domain of caveolin-1 [7,10]. Asterisks
indicate conserved aromatic amino acid residues across the family members. (B) Cartoon illustrating a possible mechanism by
which Dsg3 regulates Src activity, i.e. expression and membrane distribution of Dsg3 induced by calcium renders its binding to
Cav-1 within the caveolae and thus causes release of Src from its interaction with Cav-1, leading to auto-activation of Src that
likely associates with E-cadherin (E-cad). Cav: caveolin-1, N: N-terminus of caveolin, C: C-terminus of caveolin, pSrc: phospho-
Src.
H. Wan et al. / Data in Brief 6 (2016) 124–1341322. Experimental design, materials and methods
2.1. Antibodies
The mouse monoclonal and rabbit polyclonal Abs used were: 5H10, mouse Ab against Dsg3 (Santa
Cruz Biotechnology, Inc); HECD-1, mouse anti-E-cadherin (Abcam); Src (32G6) rabbit mAb and
phospho-Src family (Tyr416) (Cell Signaling); rabbit caveolin-1 Ab (Cell Signaling); mouse mAb
against caveolin-1 (Santa Cruz Biotechnology); rabbit anti beta actin-loading control ab8227 (Abcam);
Secondary Abs were Alexa Fluor 488 conjugated goat anti-mouse IgG and Alexa Fluor 546 conjugated
goat anti-rabbit IgG (Invitrogen).
2.2. Transient Dsg3 siRNA transfection
The siRNA sequence corresponding to nucleotides 620–640 of the respective coding region in
human Dsg3 mRNA (Accession: NM_001944.1) (AAATGCCACAGATGCAGATGA) was used to knock-
down Dsg3. The scrambled control siRNA was a randomized sequence of RNAi (AACGATGATA-
CATGACACGAG). Both sequences were synthesized by Dharmacon Research (USA). The transfection
procedures were described previously [13].
2.3. Co-immunoprecipitation (co-IP) and Western blotting
For analysis of protein in Triton X-100 -soluble and -insoluble fractions, cells were grown to freshly
conﬂuence in 100 mm Petri dishes prior to protein extraction in 500 ml of Trition X-100 lysis buffer
(10 mM Tris–HCl, pH 7.5, 150 mM NaCl, 2 mM ethyleneglycol-bis-(β-aminoethylether)-N,N,N0,N0-tet-
raacetic acid (EGTA), 5 mM ethylenediamine tetraacetic acid (EDTA), 1%Triton X-100, 1 mM phe-
nylmethylsufonyl ﬂuoride and protease inhibitor cocktail (Boehringer Mannheim)) for 10 min at 4 °C.
After centrifugation the supernatant was denoted as the Triton X-100 soluble fraction and the
H. Wan et al. / Data in Brief 6 (2016) 124–134 133undissolved pellet subsequently was extracted in 200 ml RiPA buffer. After centrifugation the super-
natant was collected and lysate was denoted as the Triton X-100 insoluble fraction. Protein con-
centration for each fraction was determined. 500 mg of protein in each fraction was used for co-IP
experiment. For total cell lysate preparation, conﬂuent cell cultures were washed with ice-cold PBS
and lysed in ice cold RIPA buffer (Upstate) containing a protease-inhibitor cocktail (Calbiochem), for
10 min at 4 °C. Then lysates were clariﬁed by microcentrifugation. The amount of 500 mg of total
protein in each sample, as determined by DC protein assay (Bio-Rad), was used for IP. The rabbit
caveolin antibody were coupled with Dynabeads (Invitrogen) for 3 h before addition into each lysate
and incubated overnight at 4 °C with rotation. Immunoprecipitates were washed thoroughly prior to
resuspension in 2 Laemmli sample buffer and boiled for 3 min. Aliquots of the denatured proteins
were separated by SDS-PAGE and processed for Western blotting.2.4. Duolink in situ proximity ligation assay for protein:protein interactions
Duolink proximity ligation assay (PLA) kit, composed of anti-mouse PLA probe plus, anti-rabbit
PLA probe minus and detection kit 563, was purchased from Olink Bioscience (Cambridge Bioscience,
UK). PLA assay was conducted following the protocol described with the kit. Brieﬂy, cells grown on
coverslips were ﬁxed and then blocked with 10% goat serum (Sigma) for 15 min followed by incu-
bation with primary antibody for 1 h at 37 °C. After this, coverslips were subjected to sequential
incubation with PLA (plusþminus) probes for 2 h, hybridization for 15 min, ligation with ligase for
15 min, ampliﬁcation with polymerases for 90 min and ﬁnally detection for 1 h. All these incubations
were carried out at 37 °C and the coverslips were washed with 1TBS-T under gentle agitation for 2–
5 min between each incubation step. Finally, the samples were mounted and analyzed using a Leica
DM5000 epi-ﬂuorescence microscope. The negative control in this assay was A431-V cells labeled
with mouse Dsg3 Ab (5H10) and rabbit anti-Myc tag Ab. The experimental samples were HaCaT cells
labeled with mouse Dsg3 (5H10) and rabbit Cav-1 Ab or rabbit anti-Src, respectively. Statistical
analysis was performed with Student's t-test and po0.05 was considered statistically signiﬁcant.2.5. Immunoﬂuorescence, confocal microscopy and colocalization analysis
For confocal analysis, cells were seeded at conﬂuent or sub-conﬂuent density on coverslips for one
day. Then, cells were ﬁxed with ice cold methanol and immune-ﬂuorescently labeled using the mouse
Dsg3 Ab (5H10)/ rabbit anti-caveolin-1 (in Fig. 1D) or the indicated antibody combinations (in Fig. 2).
Coverslips were blocked with 10% goat serum for 20 min before the primary antibody incubation for
1 h at room temperature, followed by three washes for 5 min in PBS with 0.2% Tween 20. The sec-
ondary antibodies were Alexa 488 mouse IgG/ Alexa 546 rabbit IgG (Fig. 1D) or Alexa 488 rabbit IgG/
Alexa 546 mouse IgG (Fig. 2) and all were incubated for 1 h at room temperature. After two washes,
coverslips were counterstained with DAPI for 10 min before a ﬁnal wash and then mounted on slide.
All antibodies were diluted at 1:100 in blocking buffer. Image stacks were acquired with Zeiss510
confocal microscope and analyzed with ImageJ for image processing and colocalization of double
stained proteins. The presented images in Fig. 1D were Z projection with maximum intensity and in
Fig. 2 were single confocal slice acquired at the highest protein expressing level in each region. The
Colocalization Finder tool was used for colocalization analysis and the proﬁles of IMF staining at the
cell borders were analyzed with a Segmented Lines tool with a line width of 20 pixels. All graphs were
plotted in Excel.2.6. Protein sequence alignment
The protein sequence alignment analysis was performed using the MUSCLE program [14]. The
amino acids are colored according to the Clustal X Coloring Scheme [15].
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